133 related articles for article (PubMed ID: 10698042)
1. Decreased expression of mac25 mRNA in uterine leiomyomata compared with adjacent myometrium.
Kim JG; Kim MH; Kim IS; Moon SY; Kang SB; Lee HP; Lee JY
Am J Reprod Immunol; 2000 Jan; 43(1):53-7. PubMed ID: 10698042
[TBL] [Abstract][Full Text] [Related]
2. Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women.
Vollenhoven BJ; Pearce P; Herington AC; Healy DL
Clin Endocrinol (Oxf); 1994 Apr; 40(4):537-44. PubMed ID: 8187322
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotrophin releasing hormone agonist-induced tumour regression.
Dou Q; Tarnuzzer RW; Williams RS; Schultz GS; Chegini N
Mol Hum Reprod; 1997 Nov; 3(11):1005-14. PubMed ID: 9433928
[TBL] [Abstract][Full Text] [Related]
4. Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling.
Levens E; Luo X; Ding L; Williams RS; Chegini N
Mol Hum Reprod; 2005 Jul; 11(7):489-94. PubMed ID: 16123076
[TBL] [Abstract][Full Text] [Related]
5. Different expression of estrogen receptors alpha and beta in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment.
Wang H; Wu X; Englund K; Masironi B; Eriksson H; Sahlin L
Gynecol Endocrinol; 2001 Dec; 15(6):443-52. PubMed ID: 11826769
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.
Chegini N; Verala J; Luo X; Xu J; Williams RS
J Soc Gynecol Investig; 2003 Apr; 10(3):161-71. PubMed ID: 12699880
[TBL] [Abstract][Full Text] [Related]
7. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells.
Luo X; Ding L; Chegini N
Mol Hum Reprod; 2006 Apr; 12(4):245-56. PubMed ID: 16571622
[TBL] [Abstract][Full Text] [Related]
8. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
Luo X; Levens E; Williams RS; Chegini N
Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor 1 messenger RNA expression and molecular evidence for del(7)(q22) in uterine leiomyomas.
Sourla A; Polychronakos C; Zeng WR; Nepveu A; Kukuvitis A; Naud F; Koutsilieris M
Cancer Res; 1996 Jul; 56(13):3123-8. PubMed ID: 8674071
[TBL] [Abstract][Full Text] [Related]
10. mRNA-expression of often used house-keeping genes and the relation between RNA and DNA are sex steroid-dependent parameters in human myometrium and fibroids.
Wu X; Englund K; Lindblom B; Blanck A
Gynecol Obstet Invest; 2003; 55(4):225-30. PubMed ID: 12904697
[TBL] [Abstract][Full Text] [Related]
11. Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy.
Luo X; Ding L; Xu J; Williams RS; Chegini N
Endocrinology; 2005 Mar; 146(3):1074-96. PubMed ID: 15604208
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone receptor messenger ribonucleic acid expression in leiomyoma and surrounding myometrium.
Sharara FI; Nieman LK
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):814-9. PubMed ID: 7573249
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata.
Giudice LC; Irwin JC; Dsupin BA; Pannier EM; Jin IH; Vu TH; Hoffman AR
Hum Reprod; 1993 Nov; 8(11):1796-806. PubMed ID: 7507128
[TBL] [Abstract][Full Text] [Related]
14. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
[TBL] [Abstract][Full Text] [Related]
15. Oxytocin receptor and its messenger ribonucleic acid in human leiomyoma and myometrium.
Lee KH; Khan-Dawood FS; Dawood MY
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 1):620-7. PubMed ID: 9757961
[TBL] [Abstract][Full Text] [Related]
16. Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium.
Vollenhoven BJ; Herington AC; Healy DL
J Clin Endocrinol Metab; 1993 May; 76(5):1106-10. PubMed ID: 7684390
[TBL] [Abstract][Full Text] [Related]
17. Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy.
Dou Q; Zhao Y; Tarnuzzer RW; Rong H; Williams RS; Schultz GS; Chegini N
J Clin Endocrinol Metab; 1996 Sep; 81(9):3222-30. PubMed ID: 8784073
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of latent TGF-beta binding protein-1 and fibrillin-1 in human uterine leiomyomata.
Zhao Y; Wen Y; Polan ML; Qiao J; Chen BH
Mol Hum Reprod; 2007 May; 13(5):343-9. PubMed ID: 17360930
[TBL] [Abstract][Full Text] [Related]
19. Expression of sex hormone-binding globulin mRNA in uterine leiomyoma, myometrium and endometrium of human subjects.
Misao R; Nakanishi Y; Fujimoto J; Tamaya T
Gynecol Endocrinol; 1995 Dec; 9(4):317-23. PubMed ID: 8629461
[TBL] [Abstract][Full Text] [Related]
20. Expression of exon 5 deleted estrogen receptor variant messenger RNA in human uterine myometrium and leiomyoma.
Mito K; Tamura T; Hosokawa K; Kondo T; Yamamoto T; Honjo H
J Steroid Biochem Mol Biol; 1998 Oct; 67(1):9-16. PubMed ID: 9780024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
